Melatonin - A somniferous option which does not aggravate sleep-disordered breathing in cardiac risk patients: A Holter ECG based study

Kardiologia Polska

Volumn 70, Issue 1, 2012, Pages 24-29

  Rechciński, Tomasz ^a,b   Uznańska Loch, Barbara ^a   Trzos, Ewa ^a   Wierzbowska Drabik, Karina ^a   Krzemińska Pakuła, Maria ^a   Kasprzak, Jarosław D ^a   Kurpesa, Małgorzata ^a,b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Medical University of Lodz Bieganski Hospital   (Poland)

Author keywords

Coronary artery disease; Melatonin; Sleep apnoea syndrome

Indexed keywords

MELATONIN; PLACEBO;

ADULT; AGED; ARTICLE; BREATHING PATTERN; CARDIOVASCULAR RISK; COMPUTER PROGRAM; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAM; HUMAN; MAJOR CLINICAL STUDY; SLEEP APNEA SYNDROME;

EID: 84856305282     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Cowen PJ, Bevan JS, Gosden B et al. Treatment with beta-adreno-receptor blockers reduces plasma melatonin concentration. Br J Clin Pharmacol, 1985; 19: 258-260. (Pubitemid 16216343)
2. Lusardi P, Piazza E, Fogari R. Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24-hour study. Br J Clin Pharmacol, 2000; 49: 423-427:
3. Hernández C, Abreu J, Abreu P et al. Nocturnal melatonin plasma levels in patients with OSAS: the effect of CPAP. Eur Respir J, 2007; 30: 496-500. (Pubitemid 351182073)
4. De Chazal Ph, Heneghan C, Sheridan E et al. Automated processing of the single-lead electrocardiogram for the detection of obstructive sleep apnoea. IEEE Transactions Biomed Engineering, 2008; 50: 686-696. (Pubitemid 36723602)
5. Rechciński T, Trzos E, Wierzbowska-Drabik K et al. Melatonin for nondippers with coronary artery disease: assessment of blood pressure profile and heart rate variability. Hypertens Res, 2010; 33: 56-61.
6. Bezel R, Russi E, Kronauer H et al. Lebensbedrohliche Apnoe nach Midazolam bei einem Patientem mit obstrukivem Schlaf-Apnoe-Syndrom. Schweiz Med Wschr, 1987; 117: 579-583. (Pubitemid 17056348)
7. Cirugnotta F, Mondini S, Zucconi M et al. Zolpidem-polysomnographic study of the effect of a new hypnotic drug in sleep apnea syndrome. Pharmacol Biochem Behav, 1988; 29: 807-809. (Pubitemid 19260932)
8. Seeck-Hirschner M, Baier PC, von Freier A et al. Increase in sleep-related disturbances after treatment with sodium oxybate in patients with narcolepsy and mild obstructive sleep apnoea syndrome: two case reports. Sleep Med, 2009; 10: 154-155.
9. Brzecka A, Piesiak P, Zarȩba-Bogdał E et al. Rhythm of melatonin excretion in obstructive sleep apnoea syndrome. Pnumonol Alergol Pol, 2001; 69: 650-654.
10. Benjamin JA, Lewis KE. Sleep-disordered breathing and cardiovascular disease. Postgrad Med J, 2008; 84: 15-22. (Pubitemid 351236578)
11. Suzuki M, Guilleminault MS, Otsuka K et al. Blood pressure "dipping" and "non-dipping" in obstructive sleep apnea syndrome patients. Sleep, 1996; 19: 382-387. (Pubitemid 26256752)
12. Lenz M, Martinez D. Awakenings change results of nighttime ambulatory blood pressure monitoring. Blood Press Monit, 2007; 12: 9-15. (Pubitemid 46276023)
13. Ożegowski S, Wilczyńska E, Piorunek K et al. Usefulness of ambulatory ECG in the diagnosis of sleep-related breathing disorders. Kardiol Pol, 2007; 65: 1321-1328. (Pubitemid 350164187)
14. Uznańska B, Trzos E, Rechciński T et al. New methods: diagnosing sleep apnea on the basis of 24-hour ECG monitoring - Lifescreen apnea. Pol Przegl Kardiol, 2009; 11: 271-274.
15. Skinner MA, Choudhury MS, Homen SDR et al. Accuracy of monitoring for sleep-related breathing disorders in the coronary care unit. Chest, 2005; 127: 66-71. (Pubitemid 41724557)
16. Sériès F. Can improving sleep influence sleep-disordered breathing? Drugs, 2009; 69 (suppl. 2): 77-91.
17. Kryger M, Wang-Weigand S, Roth T. Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea. Sleep Breath, 2007; 11: 159-164. (Pubitemid 47307844)
18. Błaszczak R, Wysokiński A, Ciota M et al. Sleep disorders and daily sleepiness problems among patients with arterial hypertension. Pol Przegl Kardiol, 2010; 12: 109-115.